Cell therapy clinical translation: ensuring speed to clinic while mitigating risk
Shreya Shukla, Richard Dennett, Steffany Dunn
Exploring scalable, data-driven AAV manufacturing to achieve high yield and quality across serotypes
Xiaojun Liu, Chris Brown, Yeonji Kim
Lessons learned from an end-to-end digitization journey for advanced therapy workflows
Emmanuel Casasola, Joseph Higdon
Commercialization of CAR-T therapy in New Zealand: clinical insights & scalable manufacturing
Tamara Laskowski, Lawrence Cooper
Integrating microbubbles into a CAR-T workflow: more doses in a smaller footprint
Alex Sargent, Crisha Christensen